See your product the way payers do

Accelerate your knowledge of trends, decision-drivers and emerging themes in payer assessments with IQVIA's HTA Accelerator. With HTA Accelerator, you can have direct insight into payer decisions and requirements and advanced analytic capabilities to guide market access strategy from research to launch to market expansion. The HTA Accelerator shows you payer requirements by market, disease or product category. It delivers a nuanced understanding of the dynamic payer environment based on HTA reports of more than 100 agencies in 41 countries. With new drugs coming to market every month, it also provides near real-time data on recent product submissions that could affect your future plans.

Strengthen your case at every stage

Through the HTA Accelerator you have direct access to payer insights to

• Identify payer evidentiary needs and requirements
• Guide clinical trial design that include payer relevant endpoints
• Identify emerging trends and hurdles in payer assessments
• Define an RWE strategy that payers are more likely to accept
• Evaluate of the payer landscape for product in-licensing
• Learn from recent decisions in the same therapy area or in analogous situations
• Gain near-time access to information that enables faster and smarter decision- making Now you can shape trial design using the type of data that is aligned with payer requirements in your market. You can review regulatory approval to identify market access restrictions. For products in market, you can monitor payer assessments that could impact future reimbursement and pricing for your product. The information in HTA Accelerator is organized in eleven data sources starting with clinical trials followed by regulatory approvals, HTA outcomes, pricing, reimbursement, treatment costs, innovative agreements as well as country, agency and policy updates.